Stocks and Investing
Stocks and Investing
Thu, December 9, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, December 8, 2021
[ 12:00 AM ] - WOPRAI
Derek Archila Initiated (APLS) at Buy and Held Target at $84 on, Dec 8th, 2021
Derek Archila of Wells Fargo, Initiated "Apellis Pharmaceuticals, Inc." (APLS) at Buy and Held Target at $84 on, Dec 8th, 2021.
Derek has made no other calls on APLS in the last 4 months.
There are 8 other peers that have a rating on APLS. Out of the 8 peers that are also analyzing APLS, 3 agree with Derek's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Elemer Piros of "Roth Capital" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Monday, November 29th, 2021
- Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $38 on, Friday, September 10th, 2021
- Laura Chico of "Wedbush" Downgraded from Buy to Hold and Decreased Target to $39 on, Friday, September 10th, 2021
These are the ratings of the 5 analyists that currently disagree with Derek
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $72 on, Wednesday, November 24th, 2021
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $116 on, Tuesday, November 9th, 2021
- Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $70 on, Friday, September 10th, 2021
- Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $69 on, Friday, September 10th, 2021
- Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $74 on, Thursday, August 19th, 2021
Contributing Sources